. . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en setiembre de 2018"@ast . . . "9" . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@en . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@nl . "6145700" . . "article scientifique publi\u00E9 en 2018"@fr . . . . "Clement Dumont" . . . . "Stephane Culine" . . . . . . . "Joel LeMaoult" . . . . "Amory de Gouvello" . "Nathalie Rouas-Freiss" . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@en . . "Francois Desgrandchamps" . "Adrien Riviere" . "scientific article published on 04 September 2018"@en . . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells"@en . . . "wetenschappelijk artikel"@nl . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@en . . "Malika Djouadou" . . . . . . . . "Edgardo D Carosella" . . "Annabelle Goujon" . . . "Alexandra Masson-Lecomte" . "Jerome Verine" . . . . . . . . . . . . . . "69" . . . . . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@nl . . . . . . "Antonio Rivero-Juarez" . . . . "30237859" . . . . . "33160-33169" . . . . . . "im September 2018 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . . . . "2018-09-04T00:00:00Z"^^ . . . . . . . . . . . . . "10.18632/ONCOTARGET.26036" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u0432\u0435\u0440\u0435\u0441\u043D\u0456 2018"@uk . "Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells"@nl . . .